These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2823645)

  • 1. [Cytological diagnosis of myelodysplastic syndromes. Apropos of 200 cases].
    Estienne MH; Lepelley P; Zandecki M; Fenaux P; Jouet JP; Ducoulombier P; Le Baron F; Caron B; Chassaing O; Cosson A
    Ann Biol Clin (Paris); 1987; 45(4):402-8. PubMed ID: 2823645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
    Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
    Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
    Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
    Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
    Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
    Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of bone marrow study in diagnosis and prognosis of myelodysplastic syndrome.
    Saad ST; Vassallo J; Arruda VA; Lorand-Metze I
    Pathologica; 1994 Feb; 86(1):47-51. PubMed ID: 8072801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of dysmyelopoiesis in cats: 34 cases (1996-2005).
    Weiss DJ
    J Am Vet Med Assoc; 2006 Mar; 228(6):893-7. PubMed ID: 16536701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders.
    Lorand-Metze I; Ribeiro E; Lima CS; Batista LS; Metze K
    Leuk Res; 2007 Feb; 31(2):147-55. PubMed ID: 16750852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
    Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF
    Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood picture in primary hypocellular refractory anemia and idiopathic acquired aplastic anemia: an additional tool for differential diagnosis.
    Elghetany MT; Hudnall SD; Gardner FH
    Haematologica; 1997; 82(1):21-4. PubMed ID: 9107077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.
    Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S
    Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human herpesvirus 6 infection and transient acquired myelodysplasia in children.
    Kagialis-Girard S; Durand B; Mialou V; Pagès MP; Galambrun C; Bertrand Y; Negrier C
    Pediatr Blood Cancer; 2006 Oct; 47(5):543-8. PubMed ID: 16333831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDS-related bone marrow lesions--myelodysplastic features or predominant inflammatory-reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling.
    Thiele J; Zirbes TK; Bertsch HP; Titius BR; Lorenzen J; Fischer R
    Anal Cell Pathol; 1996 Aug; 11(3):141-57. PubMed ID: 8888951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of risk groups in myelodysplastic syndromes. A multicenter study.
    Belli C; Acevedo S; Bengio R; Arrossagaray G; Watman N; Rossi N; García J; Flores G; Goldztein S; Larripa I
    Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prospective clinical study of diagnosis and classification for 282 cases with primary myelodysplastic syndrome].
    Wang XQ;
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):546-9. PubMed ID: 17172130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution.
    Balduini CL; Guarnone R; Pecci A; Centenara E; Invernizzi R; Ascari E
    Haematologica; 1999 Jan; 84(1):12-6. PubMed ID: 10091387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS.
    Amigo ML; del Cañizo MC; Rios A; Garcia MA; Caballero MD; Martin A; Bermejo N; Vilches P; San Miguel JF
    Bone Marrow Transplant; 1999 May; 23(10):997-1002. PubMed ID: 10373064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS).
    Cantù Rajnoldi A; Fenu S; Kerndrup G; van Wering ER; Niemeyer CM; Baumann I;
    Ann Hematol; 2005 Jul; 84(7):429-33. PubMed ID: 15838669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.